The survival and outcome of older patients with primary aneurysmal subarachnoid haemorrhage: a 2-year follow-up, multi-centre, observational study

医学 危险系数 比例危险模型 内科学 蛛网膜下腔出血 动脉瘤 生存分析 优势比 糖尿病 观察研究 外科 置信区间 内分泌学
作者
Bangyue Wang,Chao Peng,Hong Jiang,Yang Zhong-liang,Yan Zhao,Yunfei Song,Li J,Yifan Yang,Zhen Wang,Hengrui Zhang,Zhuolin Wu,Jianzhong Cui,Xinyu Yang,Fuguang Hu
出处
期刊:Age and Ageing [Oxford University Press]
卷期号:52 (11) 被引量:1
标识
DOI:10.1093/ageing/afad202
摘要

The management of older aneurysmal subarachnoid haemorrhage (aSAH) cases is a clinical challenge. This study aimed to analyse the survival and functional outcomes in older aSAH patients (age ≥ 70 years) to provide evidence for making treatment decisions for such patients.We performed a 2-year follow-up analysis of the Chinese Multi-Centre Cerebral Aneurysm Database for older patients suffering from aSAH from 2017 to 2020. A survival analysis was used to investigate the mean survival and hazard ratios for death. Binary logarithmic regression was performed to investigate the odds ratio for independent survival and dependent survival.A total of 1,136 consecutive older patients with aSAH were assessed in this study, and 944 patients (83.1%) were followed up. The overall mean survival was 37.79 ± 1.04 months. A total of 380 (40.25%) patients died within 2 years after aSAH. In survival analysis, the predictors of mortality were older age, intracerebral haemorrhage (ICH) history, Hunt-Hess (H-H) grade, World Federation of Neurosurgical Societies (WFNS) grade and operative treatment decreased the risk of mortality compared to conservative treatment. In binary logarithmic regression, the predictors of dependent survival were hypertension, diabetes, WFNS grade.The risk for 2-year mortality after aSAH increases markedly with older age, ICH history, H-H grade and WFNS grade. Risk factors for 2-year dependent survival were associated with hypertension, diabetes and WFNS grade in older patients with aSAH. Operative treatment markedly decreased mortality but did not significantly decrease the morbidity of dependent survival compared to conservative treatment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
顾矜应助勤奋曼雁采纳,获得10
1秒前
1秒前
小玉完成签到 ,获得积分10
1秒前
1秒前
colinbar发布了新的文献求助10
2秒前
2秒前
yeSui3yi应助芳凤凤凤iona采纳,获得10
2秒前
马哈哈发布了新的文献求助20
2秒前
刘二炮完成签到,获得积分10
2秒前
小曾完成签到,获得积分10
2秒前
英俊的铭应助陈陈采纳,获得10
3秒前
4秒前
英俊的铭应助JOE采纳,获得10
4秒前
wanci应助wp采纳,获得10
4秒前
SCH完成签到,获得积分10
4秒前
小尾巴完成签到 ,获得积分10
5秒前
5秒前
领导范儿应助清脆安南采纳,获得10
5秒前
5秒前
科研通AI6.3应助真诚采纳,获得10
5秒前
5秒前
6秒前
xiaoliu发布了新的文献求助10
6秒前
脑壳疼完成签到,获得积分10
6秒前
在水一方应助查查采纳,获得10
6秒前
Ying瀅完成签到,获得积分20
6秒前
7秒前
所所应助zy采纳,获得10
7秒前
科研通AI6.3应助adelle采纳,获得20
7秒前
8秒前
陈ber裤腰带完成签到,获得积分10
8秒前
陈格发布了新的文献求助30
8秒前
宋妙颖完成签到,获得积分20
8秒前
8秒前
9秒前
牛子哥完成签到,获得积分20
9秒前
量子星尘发布了新的文献求助10
9秒前
10秒前
彭于晏应助明天剪纸采纳,获得10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Social Work and Social Welfare: An Invitation(7th Edition) 410
Medical Management of Pregnancy Complicated by Diabetes 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6056656
求助须知:如何正确求助?哪些是违规求助? 7889514
关于积分的说明 16291597
捐赠科研通 5201985
什么是DOI,文献DOI怎么找? 2783387
邀请新用户注册赠送积分活动 1766115
关于科研通互助平台的介绍 1646904